APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
NAX compounds
PDAC
TP53
berberine
mutant TP53 reactivators
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
08 02 2022
08 02 2022
Historique:
received:
11
01
2022
revised:
04
02
2022
accepted:
04
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. In ~75% of PDAC, the tumor suppressor
Identifiants
pubmed: 35204775
pii: biom12020276
doi: 10.3390/biom12020276
pmc: PMC8961609
pii:
doi:
Substances chimiques
Quinuclidines
0
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Berberine
0I8Y3P32UF
eprenetapopt
Z41TGB4080
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Aging (Albany NY). 2017 Jun 12;9(6):1477-1536
pubmed: 28611316
Biomed Res Int. 2014;2014:924585
pubmed: 25045712
Sci Rep. 2018 Jul 13;8(1):10599
pubmed: 30006630
Phytother Res. 2001 May;15(3):183-205
pubmed: 11351353
J Hematol Oncol. 2020 Oct 2;13(1):130
pubmed: 33008426
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Cell Oncol. 2008;30(5):411-8
pubmed: 18791272
Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17450-17459
pubmed: 31399545
Adv Biol Regul. 2022 Jan;83:100840
pubmed: 34866036
Oncotarget. 2017 Sep 26;9(2):1885-1897
pubmed: 29416738
J Hematol Oncol. 2018 Jan 31;11(1):14
pubmed: 29386069
Cell Rep. 2021 Aug 24;36(8):109578
pubmed: 34433022
Braz J Med Biol Res. 2015 Feb;48(2):111-9
pubmed: 25517919
Oncogene. 2005 May 12;24(21):3484-91
pubmed: 15735745
Eur J Cancer. 2016 Mar;55:98-110
pubmed: 26790143
Front Oncol. 2021 Jun 11;11:642603
pubmed: 34178628
Cancer Lett. 2016 Jun 1;375(2):313-322
pubmed: 26975633
Cancers (Basel). 2018 Jan 20;10(1):
pubmed: 29361690
Dis Mon. 2013 Nov;59(11):368-402
pubmed: 24183261
Cell Death Dis. 2015 Jun 18;6:e1794
pubmed: 26086967
Eur J Pharmacol. 2010 Oct 25;645(1-3):70-8
pubmed: 20691179
Chem Asian J. 2016 Apr 5;11(7):1107-15
pubmed: 26865223
Oncotarget. 2015 Nov 3;6(34):36689-99
pubmed: 26452133
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):
pubmed: 34088837
Biochim Biophys Acta. 2015 Jan;1853(1):89-100
pubmed: 25311384
Ann Hepatobiliary Pancreat Surg. 2021 Aug 31;25(3):315-327
pubmed: 34402431
Oncogene. 2010 Dec 9;29(49):6442-51
pubmed: 20818419
Front Pharmacol. 2018 Aug 21;9:557
pubmed: 30186157
J Clin Oncol. 2021 May 10;39(14):1584-1594
pubmed: 33449813
Adv Biol Regul. 2021 Jan;79:100780
pubmed: 33451973
Adv Biol Regul. 2018 Aug;69:16-34
pubmed: 29980405
Cancer Discov. 2021 Aug;11(8):2094-2111
pubmed: 33839689
Clin Cancer Res. 2011 May 1;17(9):2830-41
pubmed: 21415220
Carcinogenesis. 2015 Oct;36(10):1169-79
pubmed: 26168818
Mediators Inflamm. 2010;2010:194896
pubmed: 20652055
Pancreas. 2010 May;39(4):425-35
pubmed: 20418756
Mutat Res. 2009 Mar 9;662(1-2):75-83
pubmed: 19159633
Cochrane Database Syst Rev. 2014 Feb 27;(2):CD010244
pubmed: 24578248
Acta Biochim Biophys Sin (Shanghai). 2015 Oct;47(10):824-33
pubmed: 26341980
Cochrane Database Syst Rev. 2018 Mar 20;3:CD011044
pubmed: 29557103
Cancers (Basel). 2017 Dec 16;9(12):
pubmed: 29258181
Ann Transl Med. 2019 Nov;7(22):645
pubmed: 31930046
Oncotarget. 2016 Sep 13;7(37):60245-60269
pubmed: 27533246
Prog Mol Biol Transl Sci. 2016;144:241-275
pubmed: 27865459
Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90
pubmed: 2631796
Transl Oncol. 2018 Dec;11(6):1343-1349
pubmed: 30196236
Biofactors. 2013 Nov-Dec;39(6):672-9
pubmed: 24000115
AAPS PharmSciTech. 2014 Aug;15(4):834-44
pubmed: 24696391
J Phys Chem B. 2012 Feb 23;116(7):2314-24
pubmed: 22276583
Mol Carcinog. 2015 Oct;54(10):1096-109
pubmed: 24838344
Oncogene. 2016 Aug 11;35(32):4282-8
pubmed: 26592447
Adv Biol Regul. 2019 Jan;71:172-182
pubmed: 30361003
Cell Death Dis. 2018 May 29;9(6):644
pubmed: 29844410
Biomolecules. 2020 Jun 09;10(6):
pubmed: 32526853
Eur J Pharmacol. 2012 Aug 5;688(1-3):14-21
pubmed: 22617025
Haematologica. 2020 Jun;105(6):1539-1551
pubmed: 31488557
Int J Oncol. 2013 Oct;43(4):1269-80
pubmed: 23903781
PLoS One. 2014 Dec 10;9(12):e114573
pubmed: 25493642
Cancer Genet Cytogenet. 2005 May;159(1):10-7
pubmed: 15860351
Clin Cancer Res. 2020 Jul 15;26(14):3732-3739
pubmed: 32234756
J Ovarian Res. 2016 May 14;9(1):27
pubmed: 27179933
Cancer Manag Res. 2020 Jan 30;12:695-702
pubmed: 32099466
FEBS Lett. 2014 Aug 19;588(16):2622-7
pubmed: 24768524
J Biol Chem. 2021 Jan-Jun;296:100098
pubmed: 33208462
Cell Death Dis. 2018 Apr 18;9(5):439
pubmed: 29670092
Adv Biol Regul. 2019 Aug;73:100633
pubmed: 31047842
Cell Cycle. 2014;13(5):820-33
pubmed: 24407515
Proc Natl Acad Sci U S A. 1989 Nov;86(22):8763-7
pubmed: 2530586
Breast Cancer (Dove Med Press). 2019 Jul 31;11:249-259
pubmed: 31534364
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29229669
Cancers (Basel). 2018 Jan 10;10(1):
pubmed: 29320420
Invest New Drugs. 2014 Oct;32(5):783-94
pubmed: 24838627
J Clin Oncol. 2012 Oct 10;30(29):3633-9
pubmed: 22965953
Pharmacology. 2021;106(3-4):143-153
pubmed: 32966993
Ann Intern Med. 1995 Aug 1;123(3):188-91
pubmed: 7598300
Cancer Cell. 2020 Aug 10;38(2):198-211.e8
pubmed: 32559497
Sci Rep. 2018 Aug 23;8(1):12671
pubmed: 30140002
Carcinogenesis. 2002 Dec;23(12):2011-8
pubmed: 12507923
Biochem Pharmacol. 2012 Nov 15;84(10):1260-7
pubmed: 22842630
Int J Pancreatol. 1996 Feb;19(1):31-8
pubmed: 8656025
Blood Cancer J. 2016 Jul 15;6(7):e447
pubmed: 27421096
Cells. 2021 Apr 06;10(4):
pubmed: 33917370